Skip to content
Screener

Baxter International BAX Medical Products & Therapies — Currency translation

Other segment segments

Pharmaceuticals
-$8M-147%
Healthcare Systems & Technologies
-$5M-163%

Similar metrics at other companies

Koppers Holdings logo
KOPUtility Products — Currency translation
$75K+250%
Koppers Holdings logo
KOPRailroad Products and Services — Currency translation
$0+100%
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Currency translation
$111M+464%
Viavi Solutions Inc. logo
VIAVOptical Security and Performance Products — Currency translation
$0—
Dick's Sporting Goods logo
DKSDICK’S — Currency translation
$0—
Kontoor Brands, Inc. logo
KTBLee — Currency translation
$38K+137%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2025$1,265$3,087$577$4,929
Currency translation(17)(5)(8)(30)
Balance as of March 31, 2026$1,248$3,082$569$4,899

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's medical products & therapies — currency translation?
Baxter International (BAX) reported medical products & therapies — currency translation of -$17M in Q1 2026.
How has Baxter International's medical products & therapies — currency translation changed year-over-year?
Baxter International's medical products & therapies — currency translation decreased by 144.7% year-over-year, from $38M to -$17M.
What does medical products & therapies — currency translation mean?
Captures the impact of fluctuations in foreign exchange rates on the reported financial results of the Medical Products & Therapies segment. This adjustment reconciles the difference between local currency performance and the reporting currency, highlighting exposure to international markets.

Ask your AI about Baxter International's medical products & therapies — currency translation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude